Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders
- 15 June 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (12) , 4644-4649
- https://doi.org/10.1182/blood-2003-12-4412
Abstract
In this study we investigated telomere restriction fragment (TRF) length in a panel of mature B-cell lymphoproliferative disorders (MBCLDs) and correlated this parameter with histology and histopathogenesis in relation to the germinal center (GC). We assessed 123 MBCLD samples containing 80% or more tumor cells. TRF length was evaluated by Southern blot analysis using a chemiluminescence-based assay. GC status was assessed through screening for stable and ongoing somatic mutations within the immunoglobulin heavy-chain genes. Median TRF length was 6170 bp (range, 1896-11 200 bp) and did not correlate with patient age or sex. TRF length was greater in diffuse large cell lymphoma, Burkitt lymphoma, and follicular lymphoma (medians: 7789 bp, 9471 bp, and 7383 bp, respectively) than in mantle cell lymphoma and chronic lymphocytic leukemia (medians: 3582 bp and 4346 bp, respectively). GC-derived MBCLDs had the longest telomeres, whereas those arising from GC-inexperienced cells had the shortest (P < 10-9). We conclude that (1) TRF length in MBCLD is highly heterogeneous; (2) GC-derived tumors have long telomeres, suggesting that minimal telomere erosion occurs during GC-derived lymphomagenesis; and (3) the short TRF lengths of GC-inexperienced MBCLDs indicates that these neoplasms are good candidates for treatment with telomerase inhibitors, a class of molecules currently the subject of extensive preclinical evaluation. (Blood. 2004;103:4644-4649)Keywords
This publication has 45 references indexed in Scilit:
- Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survivalBlood, 2003
- Role of Telomeres and Telomerase in the Pathogenesis of Human CancerJournal of Clinical Oncology, 2003
- Real-time polymerase chain reaction in multiple myelomaExperimental Hematology, 2002
- Mechanism of Human Telomerase Inhibition by BIBR1532, a Synthetic, Non-nucleosidic Drug CandidateJournal of Biological Chemistry, 2002
- Telomeres, aging and cancer: In search of a happy endingOncogene, 2002
- Telomerase regulation and telomere dynamics in germinal centersEuropean Journal of Haematology, 2001
- Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myelomaTransplantation and Cellular Therapy, 2000
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Telomeres shorten during ageing of human fibroblastsNature, 1990
- Conservation of the human telomere sequence (TTAGGG)n among vertebrates.Proceedings of the National Academy of Sciences, 1989